BioPharma Cell & Gene Therapy Nexus

November 11th & 12th 2026

Crowne Plaza San Diego Mission Valley, CA

0
Days
0
Hours
0
Mins
0
Secs
Be A Participant

From Cells to Cures: Driving the Future of Medicine



The BioPharma Cell & Gene Therapy Nexus 2026 is a distinguished two-day global gathering dedicated to advancing the science, development, and application of cell and gene therapies. Designed to unite senior executives from pharmaceutical and biotechnology companies with select solution providers, the Nexus offers a highly focused environment that encourages strategic dialogue, peer-to-peer learning, and meaningful professional exchange, propelling the future of advanced therapies.

This conference provides an essential stage for unveiling groundbreaking research, showcasing transformative innovations, and sharing practical advancements across the field. Participation offers the chance to connect with thought leaders, gain actionable insights, and contribute to shaping the next chapter of cell and gene therapy.

Far more than a traditional meeting, the Nexus serves as a catalyst for collaboration. It strengthens critical partnerships, accelerates the translation of pioneering science into clinical practice, and brings together diverse stakeholders to drive innovation, disseminate expertise, and ultimately improve patient outcomes worldwide.

Agenda at a Glance

Cell Therapy

Cell Therapy

Unlock next-generation approaches in autologous and allogeneic cell therapy manufacturing, combining automation, decentralized production, and efficient scale-up strategies to drive cost efficiency and improve product consistency.

Gene Therapy

Gene Therapy

Enhance gene therapy manufacturing efficiency through advanced upstream and downstream solutions. Enable faster approvals with integrated analytics, optimized process control, and comprehensive characterization while ensuring product quality and consistency.

Breakthrough Speaking Sessions

Breakthrough Speaking Sessions

This is not a conventional tradeshow, it is a highly curated gathering designed to inspire meaningful exchange. Featuring an immersive program of keynote addresses, expert panels, interactive roundtables, and poster presentations, the event provides a dynamic environment for dialogue and discovery.

A Premium, All-Inclusive Experience

A Premium, All-Inclusive Experience

Every delegate at the Cell & Gene Therapy Nexus 2026 is treated as a VIP. From curated networking sessions to thoughtfully designed experiences, the Nexus fosters meaningful collaboration and personal comfort, creating the ideal environment for advancing dialogue, building partnerships, and driving progress in cell and gene therapy.

Master the Art of Seamless Conversation

Master the Art of Seamless Conversation

Network with top decision-makers and explore how you can outsource cell and gene therapy solutions tailored to your specific needs. Engage in meaningful, one-to-one discussions to identify the right partners and drive effective collaborations.

Unlock One-to-One Engagements

Unlock One-to-One Engagements

Connect with fellow delegates through dedicated one-to-one meetings designed to foster collaboration in cell and gene therapy. This flexible format enables you to explore strategic partnerships, exchange insights, and maximize every interaction, ensuring meaningful dialogue and impactful connections throughout the event.

Who Should Attend?

By Seniority Level
30%
43%
22%
5%
Top Management (C-Suite, Presidents)
Senior Management (VPs, Heads)
Middle Management (Directors, Managers)
Others
By Geographical
50%
25%
12%
10%
3%
West Coast, USA
East Coast, USA
Europe
Central USA
Others
  • Cell Biology & Stem Cell Research
  • Gene Editing & CRISPR Technologies
  • Viral Vector Development & Engineering
  • Non-Viral Delivery Systems
  • Immunology & Immune Cell Engineering
  • Translational Research & Clinical Development
  • Preclinical & Nonclinical Development
  • Manufacturing & Process Development
  • Analytical Development & Quality Control
  • Regulatory Science & Compliance in Advanced Therapies
  • Biomarker Discovery & Companion Diagnostics
  • Oncology Cell & Gene Therapy Innovation
  • Rare Disease Therapeutics Development
  • Nucleic Acid Therapeutics (DNA, RNA, mRNA)
  • Synthetic Biology & Advanced Therapeutic Platforms
  • Bioinformatics, AI/ML & Computational Biology
  • Modeling & Simulation for Therapy Development
  • CTGs & Clinical Trial Design & Operations
  • Patient Access & Commercialization Strategies
  • Safety, Toxicology & Risk Assessment in Gene Therapy
  • Commercialization & Reimbursement
  • Data Science & Digital Tools for Advanced Therapies

Our Industry Leaders

Meet the Innovators Driving the Next Era of CGT

Amy Shaw
Amy Shaw

Head of Process & Product Development

Takeda

LinkedIn
Vaishali Shukla
Vaishali Shukla

VP CGT & API Global Expansion

Eli Lilly and Company

LinkedIn
Bernd Muehlenweg
Bernd Muehlenweg

SVP, Cell Therapy - Global BD iPSC

Evotec

LinkedIn
Marion Hitchcock
Marion Hitchcock

Managing Director Gene & Cell Therapies Incubator Berlin

Bayer

LinkedIn
Erin Kimbrel
Erin Kimbrel

Head of Cell & Gene Therapy Research

Astellas Pharma

LinkedIn
Olivia Candini
Olivia Candini

Head of Process Development, Cell & Gene Therapy

Evotec Modena

LinkedIn
Markus Haindl
Markus Haindl

Global Head, Gene Therapy Technical R&D

Roche-Genentech

LinkedIn
Emanuela Offidani
Emanuela Offidani

Executive Director, Translational Research

Precigen

LinkedIn
Kennedy (Chieme) Okechukwu
Kennedy (Chieme) Okechukwu

Senior Scientist

Iovance Biotherapeutics

LinkedIn
Anka G. Ehrhardt
Anka G. Ehrhardt

Director, Cell-Based Sciences

Merck

LinkedIn
Ajinkya Sase
Ajinkya Sase

Application Scientist

Vector Biolabs

LinkedIn
Eric B. Kmiec
Eric B. Kmiec

Chief Scientific Officer

CorriXR Therapeutics

LinkedIn
Johanna Hansen
Johanna Hansen

Senior Director (Vaccines / Bispecifics)

Regeneron

LinkedIn
Sandra Milasta
Sandra Milasta

Senior Principal Scientist

AbbVie

LinkedIn
James Stambuli
James Stambuli

Director II, Immunology Discovery

AbbVie

LinkedIn
Ilayaraja Muthuramu
Ilayaraja Muthuramu

Principal Scientist

Johnson & Johnson Innovative Medicine

LinkedIn
Payal Arora
Payal Arora

Director, Translational Research & Precision Medicine

Kyowa Kirin

LinkedIn
Deidre Dalmas
Deidre Dalmas

Distinguished Research Fellow

Boehringer Ingelheim

LinkedIn
Kambiz Shekdar
Kambiz Shekdar

Founder & CEO

Secondcell Bio

LinkedIn
Paulo Roberto Pascarella
Paulo Roberto Pascarella

Senior Scientist

Ferring Ventures

LinkedIn

What to expect at the Cell & Gene Therapy Nexus 2026

  • CGT’s Advancements: From Basics to Clinical Applications
  • Gene Editing Breakthroughs and Translational Research
  • Streamlining Manufacturing for Global Accessibility
  • Regulatory Landscape and Commercialization Strategies
  • AI & Digital Transformation in Cell & Gene Therapy

We are bringing together leading researchers, clinicians, biotech and pharma executives, solution providers, and investment leaders from across the global biopharmaceutical ecosystem. The event covers the full spectrum of the field, from foundational research and clinical translation to manufacturing, commercialization, and patient impact. With manufacturing involving living cells and complex gene delivery systems, the conference emphasizes the specialized facilities, logistics, and expertise required, while showcasing pioneering breakthroughs and strategies that are driving progress from cells to cures.

Join us to connect, collaborate, and contribute to the next wave of breakthroughs in cell and gene therapy, advancing the frontiers of biology and medical science. This is your opportunity to gain valuable insights, practical strategies, and meaningful industry connections.

  • Engage with Industry Leaders & Build Strategic Connections
  • Shape the Conversation
  • High-level plenaries with leading cell & gene therapy experts.
  • Interactive sessions exploring emerging technologies and innovative approaches in advanced therapies.
  • Targeted networking designed to foster collaborations and scientific partnerships
  • Connect with senior therapy leaders and solution providers in an exclusive, invitation-only setting.
  • Take home applicable frameworks and case studies to strengthen therapy development productivity.
  • Keep pace with emerging scientific, technological, and strategic trends shaping cell & gene therapy.

Showcase Your Solutions at the BioPharma Cell & Gene Therapy Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative cell & gene therapy solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of advanced therapies and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real impact in the cell & gene therapy ecosystem.

Schedule At a Glance

9:10 am - 09:20 am
Registration
09:20 am - 09:25 am
Welcome & Chairperson Address
09:30 am - 09:50 am
Presentation: Building a CAR-T Manufacturing Facility from a Greenfield to Operation
09:55 am - 10:15 am
Presentation: Gene Therapy Vector Production: Advancements and Innovations
10:20 am - 11:20 am
Panel Discussion: The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
11:20 am - 12:50 pm
Networking Break
12:50 pm - 01:10 pm
Presentation: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing
01:10 pm - 01:30 pm
Presentation: (Open Slot)
01:35 pm - 01:55 pm
Presentation: (Open Slot)
02:00 pm - 02:40 pm
Lunch Break: Hot Buffet Lunch will be Served.
02:45 pm - 03:00 pm
Presentation: Applying Viral Vector Vaccine Learnings to Gene Therapy: To Expect the Unexpected
3:05 pm - 04:05 pm
Panel Discussion: From Bench to Bedside: Tech Transfer Success Stories
04:05 pm - 04:25 pm
Presentation: (Open Slot)
04:30 pm - 04:50 pm
Presentation: (Open Slot)
04:50 pm - 05:20 pm
Networking Break
05:20 pm - 05:30 pm
Closing Remarks
9:10 am - 09:20 am
Registration
09:20 am - 09:25 am
Welcome & Chairperson Address
09:30 am - 09:50 am
Presentation: Automated, Dynamic Expansion of Allogeneic NK Cells: A Modular Platform Technology from the Project “RNAuto”
09:55 am - 10:15 am
Presentation: (Open Slot)
10:20 am - 11:20 am
Panel Discussion: CGT’s Manufacturing Success Stories from Different Companies/Regions
11:20 am - 12:50 pm
Networking Break
12:50 pm - 01:10 pm
Presentation: AI-Guided AAV Engineering: Deep learning for better capsids.
01:10 pm - 01:30 pm
Presentation: Integrating Automated Fill/Finish for CGT Orphan Drugs
01:35 pm - 01:55 pm
Presentation: Navigating the Evolving Regulatory Landscape for Cell and Gene Therapies
02:00 pm - 02:40 pm
Lunch Break: Hot Buffet Lunch will be Served.
02:45 pm - 03:00 pm
Presentation: (Open Slot)
3:05 pm - 04:05 pm
Panel Discussion: Precision Genome Editing: From Target Discovery to Clinical Application
04:05 pm - 04:25 pm
Presentation: Global Collaboration for Streamlining Manufacturing Processes
04:30 pm - 04:50 pm
Presentation: (Open Slot)
04:50 pm - 05:20 pm
Networking Break
05:20 pm - 05:30 pm
Closing Remarks

0

+

Seats

0

Hours

0

+

Speakers

0

+

Exhibitors

Testimonials

Venue

Crowne Plaza San Diego Mission Valley

Name: Crowne Plaza San Diego Mission Valley

Address: 2270 Hotel Cir N, San Diego, CA 92108, United States

CONFERENCE REGISTRATION

Secure your spot today.